Annexon: Preserving Patient Function Is The Real Investment Opportunity
Annexon targets functional recovery in geographic atrophy and Guillain-Barré syndrome, with ARCHER II vision-endpoint data due in Q4 2026…
Equity Eagle 3 clicksNASDAQ
Annexon, Inc.
ANNX
1 story
$796M Market cap · 2026-11-09
Get ANNX news in Claude, ChatGPT or your own code. See plans
Equity Eagle 3 clicks